Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana R Sousa

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Allergy|July 13, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysisWytske J Fokkens, Joaquim Mullol, David Kennedy, et al.
The Journal of Allergy and Clinical Immunology|November 19, 2013
Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patientsSumit Gupta, Ruth Hartley, Umair T Khan, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2017
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trialClaus Bachert, Ana R Sousa, Valerie J Lund, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 20, 2020
Airway Elastin is increased in severe asthma and relates to proximal wall area: histological and computed tomography findings from the U-BIOPRED severe asthma studySusan J Wilson, Jonathan A Ward, Helen M Pickett, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
Thorax|April 6, 2016
Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction modelRik J B Loymans, Persijn J Honkoop, Evelien H Termeer, et al.
Lancet (London, England)|March 4, 2025
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trialsPhilippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 18, 2018
Exacerbations in Adults with Asthma: A Systematic Review and External Validation of Prediction ModelsRik J B Loymans, Thomas P A Debray, Persijn J Honkoop, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2013
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthmaDhananjay Desai, Christopher Newby, Fiona A Symon, et al.
American Journal of Respiratory and Critical Care Medicine|December 8, 2016
A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED CohortsJeannette Bigler, Michael Boedigheimer, James P R Schofield, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Allergy|July 13, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysisWytske J Fokkens, Joaquim Mullol, David Kennedy, et al.
The Journal of Allergy and Clinical Immunology|November 19, 2013
Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patientsSumit Gupta, Ruth Hartley, Umair T Khan, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2017
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trialClaus Bachert, Ana R Sousa, Valerie J Lund, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 20, 2020
Airway Elastin is increased in severe asthma and relates to proximal wall area: histological and computed tomography findings from the U-BIOPRED severe asthma studySusan J Wilson, Jonathan A Ward, Helen M Pickett, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
Thorax|April 6, 2016
Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction modelRik J B Loymans, Persijn J Honkoop, Evelien H Termeer, et al.
Lancet (London, England)|March 4, 2025
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trialsPhilippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 18, 2018
Exacerbations in Adults with Asthma: A Systematic Review and External Validation of Prediction ModelsRik J B Loymans, Thomas P A Debray, Persijn J Honkoop, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2013
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthmaDhananjay Desai, Christopher Newby, Fiona A Symon, et al.
American Journal of Respiratory and Critical Care Medicine|December 8, 2016
A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED CohortsJeannette Bigler, Michael Boedigheimer, James P R Schofield, et al.
Pageof 8